Search

Your search keyword '"P. Horby"' showing total 401 results

Search Constraints

Start Over You searched for: Author "P. Horby" Remove constraint Author: "P. Horby"
401 results on '"P. Horby"'

Search Results

51. Ribavirin for treating Lassa fever: A systematic review of pre-clinical studies and implications for human dosing.

52. A standardised Phase III clinical trial framework to assess therapeutic interventions for Lassa fever.

54. The impact of viral mutations on recognition by SARS-CoV-2 specific T cells

55. Ten months of temporal variation in the clinical journey of hospitalised patients with COVID-19: An observational cohort

56. Vitamin D insufficiency in COVID-19 and influenza A, and critical illness survivors: a cross-sectional study

59. Within-host evolutionary dynamics of seasonal and pandemic human influenza A viruses in young children

60. Time to reconsider the role of ribavirin in Lassa fever.

62. Corticosteroid therapy for critically ill patients with COVID-19: A structured summary of a study protocol for a prospective meta-analysis of randomized trials

63. Interpretations of Studies on SARS-CoV-2 Vaccination and Post-acute COVID-19 Sequelae.

64. Clinical REsearch During Outbreaks (CREDO) Training for Low- and Middle-Income Countries

65. A systematic review of clinical guidelines on the management of acute, community-acquired CNS infections

66. Increase in Enterovirus D68 Infections in Young Children, United Kingdom, 2006–2016

67. A rapid research needs appraisal methodology to identify evidence gaps to inform clinical research priorities in response to outbreaks—results from the Lassa fever pilot

68. Ethics preparedness: facilitating ethics review during outbreaks - recommendations from an expert panel

69. International Biological Reference Preparations for Epidemic Infectious Diseases

70. Aetiology of acute respiratory infection in preschool children requiring hospitalisation in Europe—results from the PED-MERMAIDS multicentre case–control study

71. Evaluating clinical characteristics studies produced early in the Covid-19 pandemic: A systematic review.

73. Phase 2a, open-label, dose-escalating, multi-center pharmacokinetic study of favipiravir (T-705) in combination with oseltamivir in patients with severe influenza

74. Human plague: An old scourge that needs new answers.

75. COVID-19 and risks to the supply and quality of tests, drugs, and vaccines

76. Long-term clinical prognosis of human infections with avian influenza A(H7N9) viruses in China after hospitalization

77. Pharmacokinetics of TKM-130803 in Sierra Leonean patients with Ebola virus disease: plasma concentrations exceed target levels, with drug accumulation in the most severe patients

78. Clinical assessment is a neglected component of outbreak preparedness: evidence from refugee camps in Greece

81. An open-label, randomized, non-inferiority trial of the efficacy and safety of ciprofloxacin versus streptomycin + ciprofloxacin in the treatment of bubonic plague (IMASOY): study protocol for a randomized control trial

83. Evaluation of the efficacy and safety of intravenous remdesivir in adult patients with severe COVID-19: study protocol for a phase 3 randomized, double-blind, placebo-controlled, multicentre trial

84. Can we make human plague history? A call to action

86. Immunomodulatory therapy in children with paediatric inflammatory multisystem syndrome temporally associated with SARS-CoV-2 (PIMS-TS, MIS-C; RECOVERY): a randomised, controlled, open-label, platform trial

87. Whole-genome sequencing reveals host factors underlying critical COVID-19

91. The Breadth of Viruses in Human Semen

93. Performance of different clinical trial designs to evaluate treatments during an epidemic.

94. Seasonality of absolute humidity explains seasonality of influenza-like illness in Vietnam

96. GOST: A generic ordinal sequential trial design for a treatment trial in an emerging pandemic.

97. Empagliflozin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial

98. Raw Pig Blood Consumption and Potential Risk for Streptococcus suis Infection, Vietnam

99. Epidemiology, Clinical Manifestations, and Outcomes of Streptococcus suis Infection in Humans

100. Priorities, Barriers, and Facilitators towards International Guidelines for the Delivery of Supportive Clinical Care during an Ebola Outbreak: A Cross-Sectional Survey

Catalog

Books, media, physical & digital resources